|
| |
| | | 62812 | | 17.01.2014 | | Novartis Pharma Schweiz AG | | | | | | | | | | | | | 07.16.40. | | | | 07.16.40. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Votubia 2 mg | dispergierbare Tabletten | Dispersible Tablets (Everolimus 2 mg) | L01XE10 | CI | | 02 | Votubia 3 mg | dispergierbare Tabletten | Dispersible Tablets (Everolimus 3 mg) | L01XE10 | CI |
|
|
|
